Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded by Sandy Naidu, Marathon Fund is a venture capital firm based in the United States, focusing on pre-seed and seed stage investments. The fund has made over 50 investments and emphasizes backing founders who demonstrate commitment in their ventures.
Marathon Fund invests between $25K and $250K in early-stage companies across three primary sectors: health, future of work, and global mobility. In health, they target areas like fertility, nutrition, and longevity. Their future of work investments include AI-native productivity tools and platforms enhancing team collaboration, while global mobility focuses on cross-border infrastructure and immigration technology.
Marathon Fund's portfolio includes notable companies such as Flora, focused on fertility solutions; Fuelin and Vitract, both in the health sector; Replit, a developer platform; and Anthropic and Perplexity, both engaged in AI technologies. Additionally, Ambient works on global mobility solutions.
Sandy Naidu is the founder of Marathon Fund, bringing experience in venture capital and a focus on early-stage investments in health, AI, and mobility sectors.
Email sandy@marathonfund.vc with your deck to pitch Marathon Fund.
Yes, Marathon Fund often leads investment rounds in the companies they back, particularly in the pre-seed and seed stages.
Marathon Fund is open to follow-on investments, especially for companies that demonstrate strong growth and alignment with their investment thesis.
The specific size of Marathon Fund's current fund is not disclosed, but they actively manage a portfolio of over 50 companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.